| HEPA 0001583771 | |||
|---|---|---|---|
| Filing Date | Form Type | Description | Document |
| 2022-06-27 | 8-K | FORM 8-K | View Document |
| 2022-06-24 | DEFA14A | DEFA14A | View Document |
| 2022-06-14 | DEFA14A | DEFA14A | View Document |
| 2022-06-06 | 8-K | FORM 8-K | View Document |
| 2022-05-31 | DEFA14A | DEFA14A | View Document |
| 2022-05-27 | 8-K | FORM 8-K | View Document |
| 2022-05-16 | 10-Q | 10-Q | View Document |
| 2022-04-29 | DEF 14A | DEF 14A | View Document |
| 2022-04-20 | PRE 14A | PRE 14A | View Document |
| 2022-04-08 | 10-K | 10-K | View Document |
| 2022-03-31 | NT 10-K | NT 10-K | View Document |
| 2022-02-14 | SC 13G/A | AMENDMENT TO SC 13G | View Document |
| 2022-02-10 | SC 13G/A | SCHEDULE 13G/A | View Document |
| 2022-01-19 | SC 13G/A | HEPION PHARMACEUTICALS, INC. | View Document |
| 2022-01-12 | 8-K | FORM 8-K | View Document |
| 2022-01-10 | 8-K | FORM 8-K | View Document |
| 2022-01-06 | 8-K | FORM 8-K | View Document |
| 2022-01-04 | SC 13G/A | SABBY 13G-A HEPA 1.03.22 | View Document |
| 2021-12-21 | 8-K | FORM 8-K | View Document |
| 2021-11-30 | 8-K | FORM 8-K | View Document |
| 2021-11-24 | EFFECT | View Document | |
| 2021-11-22 | CORRESP | View Document | |
| 2021-11-19 | S-3/A | S-3/A | View Document |
| 2021-11-16 | 8-K | FORM 8-K | View Document |
| 2021-11-15 | 10-Q | 10-Q | View Document |
| 2021-11-10 | 8-K | FORM 8-K | View Document |
| 2021-10-08 | 8-K | FORM 8-K | View Document |
| 2021-10-07 | 8-K | FORM 8-K | View Document |
| 2021-09-30 | 8-K | FORM 8-K | View Document |
| 2021-09-29 | 8-K | FORM 8-K | View Document |
| 2021-09-13 | 8-K | FORM 8-K | View Document |
| 2021-09-07 | DEF 14A | DEF 14A | View Document |
| 2021-08-23 | 8-K | FORM 8-K | View Document |
| 2021-08-23 | PRE 14A | PRE 14A | View Document |
| 2021-08-16 | 10-Q | 10-Q | View Document |
| 2021-07-26 | 8-K | FORM 8-K | View Document |
| 2021-07-13 | 8-K | FORM 8-K | View Document |
| 2021-06-25 | DEFA14A | DEFA14A | View Document |
| 2021-06-25 | 8-K | FORM 8-K | View Document |
| 2021-06-09 | 8-K | FORM 8-K | View Document |
| 2021-05-20 | 4 | OWNERSHIP DOCUMENT | View Document |
| 2021-05-20 | 4 | OWNERSHIP DOCUMENT | View Document |
| 2021-05-20 | 4 | OWNERSHIP DOCUMENT | View Document |
| 2021-05-20 | 4 | OWNERSHIP DOCUMENT | View Document |
| 2021-05-20 | 4 | OWNERSHIP DOCUMENT | View Document |
| 2021-05-20 | 4 | OWNERSHIP DOCUMENT | View Document |
| 2021-05-20 | 4 | OWNERSHIP DOCUMENT | View Document |
| 2021-05-20 | 4 | OWNERSHIP DOCUMENT | View Document |
| 2021-05-14 | 10-Q | 10-Q | View Document |
| 2021-05-12 | DEF 14A | DEF 14A | View Document |
| 2021-05-06 | 8-K | FORM 8-K | View Document |
| 2021-04-29 | 8-K | FORM 8-K | View Document |
| 2021-04-28 | PRE 14A | PRE 14A | View Document |
| 2021-04-28 | 10-K/A | FORM 10-K/A | View Document |
| 2021-04-07 | UPLOAD | View Document | |
| 2021-04-02 | S-3 | FORM S-3 | View Document |
| 2021-03-31 | 10-K | 10-K | View Document |
| 2021-03-23 | 8-K | FORM 8-K | View Document |
| 2021-03-11 | 8-K | FORM 8-K | View Document |
| 2021-02-24 | SC 13G | ACQUISITION OF BENEFICIAL OWNERSHIP | View Document |
| 2021-02-19 | SC 13G | SABBY 13G HEPA 2.19.21 | View Document |
| 2021-02-18 | 4 | OWNERSHIP DOCUMENT | View Document |
| 2021-02-18 | 4 | OWNERSHIP DOCUMENT | View Document |
| 2021-02-18 | 4 | OWNERSHIP DOCUMENT | View Document |
| 2021-02-18 | SC 13G | HEPION PHARMACEUTICALS, INC. | View Document |
| 2021-02-17 | 8-K | FORM 8-K | View Document |
| 2021-02-16 | 424B5 | 424B5 | View Document |
| 2021-02-16 | SC 13G/A | SC 13G/A | View Document |
| 2021-02-16 | 424B5 | 424B5 | View Document |
| 2021-02-12 | FWP | FWP | View Document |
| 2021-02-10 | SC 13G | SCHEDULE 13G | View Document |
| 2021-02-10 | 8-K | FORM 8-K | View Document |
| 2021-02-09 | SC 13G/A | HEPA 13GA | View Document |
| 2021-01-28 | 8-K | FORM 8-K | View Document |
| 2021-01-20 | SC 13G/A | HEPION PHARMACEUTICALS, INC. | View Document |
| 2021-01-19 | S-8 | S-8 | View Document |
| 2021-01-07 | SC 13G/A | SABBY 13G-A HEPA 1.07.21 | View Document |
| 2021-01-05 | 8-K | FORM 8-K | View Document |
| 2020-12-29 | 8-K | FORM 8-K | View Document |
| 2020-12-28 | SC 13G/A | AMENDMENT TO FORM SC 13G | View Document |
| 2020-12-22 | 8-K | FORM 8-K | View Document |
| 2020-12-21 | 4 | OWNERSHIP DOCUMENT | View Document |
| 2020-12-10 | 8-K | FORM 8-K | View Document |
| 2020-12-09 | SC 13G | SCHEDULE 13G | View Document |
| 2020-12-08 | 4 | OWNERSHIP DOCUMENT | View Document |
| 2020-12-02 | 4 | 4 | View Document |
| 2020-12-02 | SC 13G | HEPION PHARMACEUTICALS, INC. | View Document |
| 2020-12-02 | 8-K | FORM 8-K | View Document |
| 2020-12-02 | SC 13G | SABBY 13G HEPA 12.01.20 | View Document |
| 2020-12-01 | 4 | 4 | View Document |
| 2020-11-30 | 4 | 4 | View Document |
| 2020-11-27 | 8-K | FORM 8-K | View Document |
| 2020-11-25 | 424B4 | 424B4 | View Document |
| 2020-11-24 | EFFECT | View Document | |
| 2020-11-20 | CORRESP | View Document | |
| 2020-11-20 | CORRESP | View Document | |
| 2020-11-20 | S-1/A | S-1/A | View Document |
| 2020-11-20 | 8-K | FORM 8-K | View Document |
| 2020-11-18 | FWP | FWP | View Document |
| 2020-11-18 | S-1/A | S-1/A | View Document |
